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Abstract
Autophagy is the major pathway involved in the degradation of proteins and organelles, cellular
remodeling, and survival during nutrient starvation. Autophagosomal dysfunction has been
implicated in an increasing number of diseases from cancer to bacterial and viral infections and
more recently in neurodegeneration. While a decrease in autophagic activity appears to interfere
with protein degradation and possibly organelle turnover, increased autophagy has been shown to
facilitate the clearance of aggregation-prone proteins and promote neuronal survival in a number
of disease models. On the other hand, too much autophagic activity can be detrimental as well and
lead to cell death, suggesting the regulation of autophagy has an important role in cell fate decisions.
An increasing number of model systems are now available to study the role of autophagy in the
central nervous system and how it might be exploited to treat disease. We will review here the
current knowledge of autophagy in the central nervous system and provide an overview of the
various models that have been used to study acute and chronic neurodegeneration.
Background
Cells have a constant need for the building blocks of life:
amino acids, lipids, carbohydrates, and nucleic acids. To
sustain this catabolic and anabolic need, they rely on
uptake and recycling. While nutrient uptake is important,
different degradation systems are in place to efficiently
turnover recyclable intracellular material and provide
quality control. The main pathways for protein degrada-
tion and recycling are the ubiquitin/proteasome pathway
(for degrading short-lived cytosolic and nuclear proteins)
[1], the lysosomal pathway (for cytosolic proteolysis), and
autophagy (for bulk cytosolic degradation and organelle
recycling) [2]. Deficits in any of these recycling pathways
can result in uncontrolled accumulation of cellular debris
or severe deficiencies in metabolic productivity, ulti-
mately causing cell death.
The term autophagy, coined from the Greek words of αυτς
('autos', self) and φαγειν ('phagein'), meaning 'eating',
was first used in 1963 by Christian de Duve to establish a
nomenclature for different cellular pathways and com-
partments in the endosomal-lysosomal pathway [3]. Early
work in autophagy research was done in rat liver cells and
autophagy was characterized as a physiological response
to starvation in order to degrade and recycle non-essential
intracellular macromolecules [4-6]. Later, autophagy [7]
and many of the autophagy genes [8] were identified in
yeast, which gave the scientific community access to pow-
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erful cloning and pathway analysis tools. Subsequent
identification of mammalian homologues led to the
investigation of the role of autophagy in cancer, pro-
grammed cell death, tissue remodeling, heart, liver and
muscle diseases, and bacterial and viral infections [9].
In recent years, increasing attention has been focused on
the role of autophagy in metabolism of misfolded pro-
teins and neuronal cell death in neurodegeneration (for
comprehensive reviews see [10-13]). Abnormal
autophagy has been implicated in the pathology of
numerous diseases of the central nervous system (CNS),
both chronic disorders (such as proteopathies) and many
acute injuries. While it is still early in our understanding
of this pathway, autophagy seems to have both beneficial
and detrimental effects in disease, and it will be key to
define the context that determines the outcome.
Types of neuronal autophagy
Autophagy is involved in the intracellular turnover of pro-
teins and cell organelles and has an important role in reg-
ulating cell fate in response to stress [14,15]. It is a highly
conserved process that occurs in all species and cell types
studied thus far. Two main types of mammalian
autophagy have been identified and implicated in CNS
injury and disease: macroautophagy and chaperone-
mediated autophagy. Other more specialized forms of
autophagy exist, such as mitophagy (direct targeting of
mitochondria to lysosomes) [16], pexophagy (selective
degradation of peroxisomes) [17,18], xenophagy (degra-
dation of intracellular bacteria and viruses) [14,19],
crinophagy (lysosomal fusion with re-directed exosomes)
[20], microautophagy (direct engulfment of cytosol by
lysosomes) [21,22], and piecemeal microautophagy of
the nucleus (partial sequestration and degradation of the
nucleus) [23], but most of them have only been observed
in yeast or under special conditions and are not reviewed
here.
Macroautophagy is a bulk degradation pathway and the
only intracellular mechanism potentially capable of
degrading large protein aggregates or damaged organelles.
It is a well-understood process in yeast, but details about
the exact sequence of events and the proteins involved are
still uncertain in mammals. A cup-shaped isolation mem-
brane forms around cytosolic components, eventually
fusing to form a double membrane bound vesicle [24,25].
The origin of the membrane material for the formation of
the isolation membrane is still under investigation, but
recent evidence suggests that it might be derived from the
endoplasmatic reticulum (ER) [26]. The protein
MAP1LC3 is anchored via conjugated phosphatidyleth-
anolamine (MAP1LC3-II) to the isolation membrane and
is a specific marker for the so-called autophagosomes
[27]. The autophagosome undergoes several microtubule-
[28,29] and dynein-dependent maturation events
[30,31], including fusions with multivesicular bodies
(MVB), early and/or late endosomes [32,33], before it
fuses with lysosomes [34,35] (Fig. 1, for a more compre-
hensive overview of autophagosome turnover see
[28,36]).
At least 12 Atg (autophagy-related) and 4 other proteins
are known to be involved in mammalian macroau-
tophagy initiation and execution [37,38] (see Fig. 2).
Whether direct autophagosomal-lysosomal fusion is pos-
sible, or endosomes first have to deliver essential enzymes
to the maturating autophagosomes, is unclear. While the
content of the autophagosome initially has the same pH
as the surrounding cytosol, it becomes more acidic during
its maturation [39,40]. For successful degradation of the
autophagosomal content, autophagosomes need to
migrate from their site of formation to lysosome rich peri-
nuclear regions [29,41]. After fusion with the lysosome
the outer autophagosome membrane can be reused, while
lysosomal enzymes degrade the inner membrane and its
cytosolic contents, enabling the recycling of macromole-
cules [42] (Fig. 1). It is unknown which markers, if any,
label organelles or cytoplasm for sequestration and inclu-
sion into autophagosomes. One possible marker for pro-
tein aggregates is the ubiquitin binding protein
sequestosome 1 (SQSTM1, also known as p62) [43].
Almost all protein aggregates are poly-ubiquitinated and
SQSTM1 binds both, MAP1LC3 and ubiquitin [44-46].
Macroautophagy components are expressed in neurons
and neuronal cell lines (Tab. 1). While the function of
autophagy-related proteins has been described for some,
it is still unknown for others (Tab. 2). Macroautophagy
has been implicated in chronic neurodegenerative dis-
eases and acute neuronal injuries (Tab. 3 and 4).
Chaperone-mediated autophagy (CMA) is distinctly dif-
ferent from macroautophagy in that no vesicular traffick-
ing is involved (Fig. 1). Instead, a pentapeptide motif in
substrate proteins allows their specific translocation to the
lysosome membrane (reviewed in [47-49]). Thus, CMA
degrades only proteins with the motif KFERQ or a bio-
chemically related sequence, which is present in about
30% of all cytosolic proteins [50]. It has recently been sug-
gested that 80% of aminoacyl-tRNA synthases are also
substrates for CMA [48], indicating a possible role of CMA
in protein synthesis control under starvation conditions.
To be targeted for CMA, substrate proteins first bind to a
cytosolic complex containing the chaperone HSC70 (Fig.
1). This complex then interacts with a lysosomal mem-
brane complex containing LAMP2A and HSP90 [51]. The
substrate protein is finally degraded after unfolding and
translocation into the lysosomal lumen (with the help of
lys-HSC70, a luminal form of HSC70) [51]. The chaper-Molecular Neurodegeneration 2009, 4:16 http://www.molecularneurodegeneration.com/content/4/1/16
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one complex consists of many more proteins but their
exact localization and role in CMA is presently unclear
[52].
Macroautophagy and CMA are interconnected, although
the details of this crosstalk are not well understood. A pos-
sible connection is BCL2 associated athanogene (BAG1)
which functions as a nucleotide exchange factor for
HSC70 [53] and has been reported to bind MAP1LC3
[54]. Impairing macroautophagy, either genetically or
pharmacologically, results in a compensatory up-regula-
tion of CMA [55]. CMA components are expressed in neu-
rons and neuronal cell lines (Tab. 1) and CMA has also
been implicated in chronic neurodegenerative diseases
(Tab. 3).
Autophagy in the healthy nervous system
The brain is well protected against short-term periods of
systemic starvation. Selective transport of glucose, amino
acids, and hormones across the blood-brain-barrier
Steps in macroautophagy and chaperone-mediated autophagy (CMA) Figure 1
Steps in macroautophagy and chaperone-mediated autophagy (CMA). Macroautophagy: 1.) Nucleation. An unidenti-
fied membrane source delivers lipid bi-layers for the formation of the phagophore. In yeast this early structure is termed pre-
autophagosomal structure (PAS), its identity in mammalian cells is uncertain. A class III PI3K complex consisting of at least 
BECN1, PIK3C3, PIK3R4, UVRAG, and AMBRA1 is required for PAS formation and MAP1LC3 is anchored to the membrane 
via a phosphoethanolamine (PE) anchor (LC3-II). 2.) Expansion. The PAS or a comparable structure in mammals sequesters 
cytosolic cargo (either specifically via SQSTM1 [p62] or nonspecifically) by invagination, forming a double-membranous vesicle. 
This stage is also called "isolation membrane". More membrane and LC3-II is being recruited to the developing vacuole. 3.) 
Maturation. The completed autophagosome undergoes multiple maturation steps and fusion events with multi-vesicular bodies 
(MVB) or endosomes. The exact nature and sequence of this maturation, and whether these steps are always required is cur-
rently unknown. The autophagosomal lumen becomes more acidified during this maturation. 4.) Docking and fusion. During 
docking and fusion the inner membrane compartment together with its content gets released into the lysosome/autolysosome 
and is being degraded by lysosomal hydrolases. The components of the outer membrane are available for re-usage. Chaperone-
mediated autophagy: 5.) Recognition and binding. The HSC70 chaperone complex (consisting of HSC70, HSP90 and maybe 
other proteins) recognizes unfolded proteins with the KFERQ sequence and moves them to the lysosome. 6.) Translocation. 
LAMP2A and a lysosomal form of HSC70 (l-HSC70) translocate the substrate protein across the lysosomal membrane into the 
lumen for degradation. The autophagy delivered substrates get degraded inside the lysosomes and their macromolecular com-
ponents are made available to the cell's metabolism via permeases that allow their transport back into the cytosol.
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ensures ample supply of metabolites and local popula-
tions of glia cells release trophic factors under normal or
energy restricted conditions. High levels of constitutive
autophagy in neurons may therefore not be necessary to
maintain the cellular energy needs; indeed, forty-eight
hours of food deprivation caused no apparent autophagy
induction in the mouse brain [56].
Instead, autophagy probably supports local housekeeping
functions within the neuron: macroautophagy is the only
cellular mechanism capable of degrading expired
organelles in neurons that can live for decades. In addi-
tion autophagy is a potential clearing mechanism for pro-
tein aggregates that occur frequently in aging neurons, but
not in young and healthy cells. Consistent with such a role
in the normal brain autophagosome numbers [57] and
the levels of MAP1LC3-II protein [56,58,59] are low when
compared with other tissues. Nevertheless, recent findings
show that autophagy in neurons is indeed constitutively
active [60,61] and autophagosomes accumulate rapidly
when their clearance is blocked [62], indicating fast basal
turnover.
A number of autophagy related genes are expressed
(measured either by mRNA or protein analysis) in neuro-
nal tissues of humans [58,59,63-78], rodents [56,59-
61,65,75,76,79-107], and insects [97,108-116] (Tab. 1).
Electron microscopy of human and mouse brain tissue
shows the presence of lysosomes and autophagosomes in
neurons further supporting a basal level of autophagy dur-
ing normal neuronal homeostasis [57,58,117,118].
Model organisms have been crucial for the identification
of genes that regulate autophagy and clarification of their
function as detailed in Tab. 2[27,40,59-61, 79, 83, 85, 90,
91,97,99,100,107,111-116,119-146].
Age is a major risk factor for many neurodegenerative dis-
eases and a number of studies suggest a role for autophagy
in aging. Interestingly, protein degradation and specifi-
cally autophagy (both macroautophagy and CMA)
decline with age, although to what extent that reduction
occurs within the CNS is not clear [147-150]. An age
related decline of Atg genes has been shown in D. mela-
nogaster, and Atg8 overexpression increases the fly's
lifespan [151,152] while RNAi of autophagy genes in C.
elegans leads to decreased lifespan [136,153]. If and how
decreasing autophagy activity in the aging human CNS
contributes to the higher prevalence of neurodegenerative
diseases and accumulation of various protein aggregates
will have to be clarified in future studies.
Autophagy as a clearing mechanism for protein 
degradation
The strongest evidence for an active role of autophagy in
maintaining neuronal homeostasis comes from engineered
mutant mice lacking autophagy genes. While Atg5 and Atg7
knockout mice had been created before [128,130], their
early developmental mortality made the study of the adult
CNS impossible. To overcome this limitation, two land-
mark studies generated conditional knockout mice lacking
Atg5 and Atg7 only in neurons [60,61].
The Atg5flox/flox;nestin-Cre mice showed growth retarda-
tion, progressive motor and behavioral deficits, promi-
nent neurodegeneration and axonal swelling in a number
of brain regions. Histological examination also revealed
abundant ubiquitin-positive inclusions in neurons, indi-
cating a crucial role of autophagy in the turnover of dif-
fuse cytosolic proteins labeled for degradation [60].
Autophagy pathway in mammals Figure 2
Autophagy pathway in mammals. The formation of 
autophagosomes appears to follow a pathway conserved 
across species and most findings made in yeast or other 
organisms also apply to mammalian autophagy. a.) Autophagy 
can be induced via mTOR dependent or independent path-
ways (for more information, see text and Fig. 3) which stimu-
late the nucleation and expansion of the phagophore/
isolation membrane. b.) A multi-protein complex surround-
ing BECN1 with PI3K activity (mediated by PIK3C3) is 
important for the formation of the autophagosomal mem-
brane. c.) Two ubiquitin-like modification systems are essen-
tial for mammalian autophagy; ATG12 is activated by ATG7 
(E1 step), transferred to ATG10 (E2 step), conjugated to 
ATG5 and subsequently forms a complex with ATG16. This 
step is necessary early in autophagy for the formation of the 
phagophore or isolation membrane. MAP1LC3 (LC3) is 
cleaved by ATG4, activated by ATG7 (E1 step), transferred 
to ATG3 (E2 step), and conjugated to the phospholipid phos-
phoethanolamine (PE). This form known as MAP1LC3-II 
(LC3-II), localizes to the autophagosome membrane and is 
subsequently degraded in the lysosome. ATG4 cleaves off a 
C-terminal arginine (R) to expose a glycine residue that is 
then being linked to PE. Rapamycin (Rap) inhibits mTOR and 
activates macroautophagy, while 3-methyladenin (3-MA) and 
wortmannin (WM) inhibit the PI3K activity and de-activate 
macroautophagy.
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Table 1: Presence of autophagy related gene expression in neuronal tissue.
Gene H. sapiens M. musculus R. norvegicus Gene D. melanogaster Gene C. elegans
mRNA Protein AllenB
ULK1 [67] [99,100,107] Yes [92] Atg1 [97] unc-51 WoBa 
[109,110,112,113]
ATG3 [74] [104] Yes Atg4/Aut1 [111] atg-3
ATG4 [68] [90] Yes [105] Aut2/Atg4 atg-4.1-2 WoBa
ATG5 [60,91,93,96] Weak [87] Atg5 atg-5/atgr-5
BECN1 [59,69] [59,65,69] [59,81,96] Yes [80,94,95,106] Atg6 [97] bec-1 WoBa [116]
PIK3C3 [66] [77] Yes Vps34/Pi3K59F vps-34/let-512 [114]
PIK3R4 [71] Weak Vps15/ird1 ZK930.1
UVRAG [72] Yes
AMBRA1 [83] n.a.
ATG7 [75] [61,96] Weak [75] Atg7 atg-7/atgr-7
MAP1LC3 [58,65] [56,60,65,79,84,86,
96]
Yes [87-89,95,103,106] [97] lgg-2
GABARAP [78] Yes [89,92] Atg8a lgg-1 WoBa
GABARAPL2 [78] Yes [89]
ATG12 [82,96] Weak [87] Atg12 lgg-3
CHMP4B [85] n.a. shrb/Vps32 [108,115] vps-32.1 WoBa
HSPA8 [70] [63,73,76] Yes [76,98,101] Hsc70-4 hsp-1
LAMP2 [64] [102] Weak [102,103]
Examples of autophagy related gene expression in humans and common model organisms (mRNA and/or protein). For human, mouse, and rat genes the approved human gene symbol is used 
http://www.genenames.org, for D. melanogaster and C. elegans their respective gene symbols (if existent) are provided. (AllenB): Gene mRNA is detectable by hybridization as published in the 
Allen Brain Atlas http://www.brain-map.org; (WoBa): neuronal expression data available at WormBase http://www.wormbase.org; (n.a.): not available.Molecular Neurodegeneration 2009, 4:16 http://www.molecularneurodegeneration.com/content/4/1/16
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Table 2: Neuronal phenotype of autophagy related knockout/knockdown animal models.
Gene
(Alias)
Protein function Knockout/
knockdown
OE/TG ES/M @ IMSR Neuronal phenotype 
after k.o./k.d.
(Animal model)
K.o. embryonic 
lethal
ULK1
(ATG1)
Ser/Thr protein kinase 
(regulation and vesicle 
formation)
[107,112,113] *
[97,99,100,131,13
2,135,141,145]
[140] (OE) ES
M (GT)
Impaired endocytosis of 
nerve growth factor, 
excessive axon 
arborization, stunted axon 
elongation (MM)
Paralysis, aberrant axon 
growth, abnormal vesicles, 
arrested differentiation 
(CE)
Yes (DM)
ATG3 Ubiquitin-conjugating-like 
enzyme 
(attaches MAP1LC3 to PE)
[111,143] n.a. Not reported Yes (DM)
ATG4 Cystein protease (cleaves 
C-terminus of MAP1LC3 
for conjugation)
[90,144] ES
M (GT/TG)
Not reported Yes (CE)
ATG5 Unknown 
(conjugates to ATG12, 
binds ATG16)
[60] *
[91,130,141]
ES
M (MUT)
Progressive motor 
deficits, accumulation of 
inclusion bodies, 
neurodegeneration, 
aberrant vacuoles in 
Purkinje cells (MM)
No # (DM/MM)
BECN1
(ATG6)
Unknown (part of class III 
PI3K complex, anchor 
protein, autophagy 
initiation)
[59] *
[97,116,124,137,1
46]
[119] (TG) M (TG) Neurodegeneration, 
lysosomal abnormalities 
(MM)
Yes (MM/CE/DM)
PIK3C3
(VPS34)
Class III PI3K complex 
(forms complex with 
BECN1/PIK3R4/AMBRA1/
UVRAG, autophagy 
initiation)
[123,142] *
[114,126]
ES Abnormal protein 
aggregation, abnormal 
locomotion (CE)
Yes (CE)
PIK3R4
(VPS15, P150)
Ser/Thr protein kinase 
(forms a complex with and 
activates PIK3C3)
[134] ES Not reported Yes (DM)
AMBRA1 Unknown 
(component of the class III 
PI3K complex)
[83] * ES Neural tube defects, 
polyU aggregates, 
unbalanced cell 
proliferation, cell death 
(MM)
Yes (MM)
ATG7 Ubiquitin-activating-like 
enzyme (activates 
MAP1LC3 and ATG12 for 
conjugation)
[61,123,129] *
[124,125,127,128,
136,141]
ES Behavioral deficits, 
neuronal loss, polyU 
inclusions, axonal 
dystrophy, axonal terminal 
degeneration (MM)
PolyU aggregates, 
neuronal degeneration 
(DM)
Abnormal protein 
aggregation (CE)
No # (DM/MM)Molecular Neurodegeneration 2009, 4:16 http://www.molecularneurodegeneration.com/content/4/1/16
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In the Atg7flox/flox;nestin-Cre mice, strikingly similar patho-
logical changes occurred: reduced growth, motor and behav-
ior changes, loss of Purkinje cells, activation of glia cells, and
accumulation of ubiquitinated inclusions. Proteasomal
function was not impaired by autophagy inhibition, which
shows that autophagy has an important role in the basal
turnover of poly-ubiquitinated (polyU) proteins together
with the proteasome [61]. The ubiquitin-positive aggregates
also contain abnormal amounts of SQSTM1 [127].
While polyU proteins themselves are sticky but not highly
aggregating, the presence of large amounts of SQSTM1
might enhance their aggregation [43,154]. SQSTM1 can
directly interact with MAP1LC3 [45] and tags ubiquiti-
nated protein-aggregates for autophagic degradation
[43,155]. It appears that impairment of autophagy leads
to the accumulation of SQSTM1, which in turn increases
the rate of aggregation for diffuse ubiquitinated proteins.
Interestingly, the double knockout of Atg7  and Sqstm1
prevents the formation of ubiquitinated aggregates in
neurons, but has no effect on the other observed neurode-
generative phenotypes [127], indicating that autophagy
plays multiple roles in neuronal homeostasis, not just
clearance. This crosstalk between autophagy and the ubiq-
uitin-proteasome system (UPS) is supported by in vitro
induction of autophagy in response to impaired UPS
[156]. SQSTM1 is not the only protein facilitating the deg-
radation of protein aggregates via autophagy, as HDAC6,
a microtubule-associated histone deacetylase that inter-
acts with polyU proteins, also provides a link to
autophagy (see below [156,157]).
Additional evidence for a role of autophagy in protein
turnover comes from mice lacking Ambra1, a recently dis-
covered regulator of autophagy that interacts with Beclin
1 (BECN1) [83] (Fig. 2). Ambra1 knockout mice show
polyU inclusions and severe neural tube deficits, unbal-
anced cell proliferation, and excessive apoptotic cell
death. Autophagy has a complex interplay with apoptosis,
where it can serve both as an alternative cell-death and as
an anti-apoptotic survival mechanism. More details of
this relationship will be discussed at the end of this article
and comprehensive reviews have been published on this
topic elsewhere [133,158].
Autophagy in vesicle sorting and organelle 
turnover
Another set of important findings indicates that endo-
somal sorting and endosomal-autophagosomal fusion are
impaired in certain neurodegenerative diseases. ESCRT-0
MAP1LC3
(LC3)
Unknown (similarity with 
ubiquitin, part of 
autophagosomal 
membrane)
[123,145] *
[79,97]
[27] (TG) ES
M (TG)
Abnormal protein 
aggregation (CE)
Yes (CE)
No (MM)
ATG12 Unknown (similarity with 
ubiquitin, conjugated to 
ATG5)
[123] * n.a. Abnormal protein 
aggregation (CE)
Unknown
CHMP4B
(SNF7-2)
Unknown (part of the 
ESCRT-III complex, 
involved in surface 
receptor degradation, 
formation of MVBs and 
autophagosomes)
[85,115,138] ES Dendritic and axonal 
branching impaired, 
dendritic retraction, 
reduced cell viability, 
autophagosomes 
accumulate, increased htt 
toxicity (DM)
Yes (MM)
HSPA8
(HSC70)
Chaperone (recognizes 
CMA motif, lysosomal 
translocation)
[121,139] * [120] (OE) ES Impaired transmitter 
release, o.e. rescues α-
synuclein pathology, 
Bolwig's nerve projection 
abnormalities (DM)
Yes (DM)
LAMP2 Unknown (Lysosomal 
membrane glyco-protein, 
forms complex with 
HSPA8)
[40] ES Not reported No (MM)
Examples of model organism with knockout, knockdown, or overexpression of autophagy genes and the corresponding neuronal phenotype. 
Approved human gene names are used http://www.genenames.org, in addition commonly used aliases are provided. # While non-neuronal Atg5 and 
Atg7 k.o. mice survive birth, they die within one day postnatal. (MM): M. musculus; (DM): D. melanogaster; (CE): C. elegans; (OE): overexpression; 
(ES): embryonic knockout stem cell; (M): mouse line; (TG): transgenic; (GT): gene-trap; (MUT): targeted mutation; (IMSR): knockout ES/mice available 
through the International Mouse Strain Resource http://www.informatics.jax.org/imsr/index.jsp; (*): neuronal tissue examined; (n.a.): not available.
Table 2: Neuronal phenotype of autophagy related knockout/knockdown animal models. (Continued)Molecular Neurodegeneration 2009, 4:16 http://www.molecularneurodegeneration.com/content/4/1/16
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to III (endosomal sorting complex required for transport)
orchestrate the progression of endosomes along the endo-
somal-lysosomal pathway. Dysfunction of one of these
complexes (ESCRT-III), either by RNAi depletion of its
essential subunit CHMP4B (also known as SNF7-2) or by
expression of a mutant CHMP2B protein (another subu-
nit of ESCRT-III and associated with Frontotemporal
dementia linked to chromosome 3), caused autophago-
some and polyU protein aggregate accumulation, and
dendritic retraction followed by neuronal death in cul-
tured mature cortical neurons [85]. It has been suggested
that the endosomal and autophagosomal pathways merge
upstream of lysosomal fusion [159-161], in particular that
intact multivesicular bodies (MVB) are essential for
autophagosome maturation [138,162]. ESCRT-III seems
to play an important role during this endosomal-
autophagosomal fusion event and its dysfunction leads to
impaired processing and accumulation of autophago-
somes. In a recent paper, deletion of the Hrs (also known
as Hgs) gene, a component of ESCRT-0, in the neurons of
Hrsflox/flox;SynI-cre mice caused apoptosis, loss of hippoc-
ampal CA3 pyramidal neurons, and accumulation of
polyU proteins and SQSTM1 [163]. Accordingly, locomo-
tor activity and learning ability were severely reduced in
these mice.
While no evidence for the autophagosomal degradation
of specific neuronal organelles (such as synaptic vesicles)
in healthy neurons exists thus far, mitochondria were
selectively degraded by macroautophagy in neurons
exposed to experimental neurotoxins 1-methyl-4-phe-
nylpyridinium (MPP+) or 6-Hydroxydopamine, which
induce mitochondrial damage [164,165]. Autophago-
somes were also observed in dopaminergic neurons
treated with methamphetamine [166], supporting the
idea that autophagy serves to clear damaged organelles in
neurons. Together, these studies underline the critical role
of autophagosomal-endosomal-lysosomal trafficking and
sorting in neuronal homeostasis
Autophagosomes as transport vacuoles
Autophagosomes are not only found in the soma but also
in the distal parts of the axon and dendrites and can be ret-
rogradely transported to the cell soma for degradation
[167]. Autophagy may thus support neurite and growth
cone remodeling and clear axons and dendrites of defec-
Table 3: Autophagy in common chronic neurodegenerative diseases.
Disease Autophagosomal phenotype Ref.
Alzheimer disease Autophagy appears impaired, autophagosomes accumulate, 
endosomal-lysosomal abnormalities, increased mitophagy, 
reduction of macroautophagy enhances pathology, 
pharmacological activation of macroautophagy can promote 
the clearance of Aβ/APP and reduces tau pathology, 
autophagosomes contain APP/Aβ/secretases.
[206,208,59,62,204,207,203,209,205,57,58,118]
Parkinson disease Autophagy/mitophagy appears impaired, autophagosome-
like structures accumulate, pharmacological activation of 
macroautophagy enhances α-synuclein clearance and is 
neuroprotective, α-synuclein is a target of CMA and 
macroautophagy and the proteasome, dopamine-modified/
mutated α-synuclein blocks CMA and dopamine induces 
autophagic cell death and α-synuclein accumulation, mutant 
UCH-L1 binds to LAMP2A and inhibits CMA.
[220,214,215,213,219,212,102,216,192,210,211,
218,217,117]
Huntington diseases Impaired sorting/degradation of autophagosomes, 
autophagosomes accumulate, BECN1 is recruited to htt 
inclusions and BECN1 reduction causes enhanced htt 
accumulation, pharmacological or signaling mediated 
activation of macroautophagy reduces htt toxicity, mTOR is 
sequestered into htt inclusions, which causes 
macroautophagy activation.
[225,227,228,216,229-
231,203,221,226,224,195,223,222]
Frontotemporal dementia Impaired endosome maturation, enlarged autophagosome 
accumulation, mutant CHMP2B disturbs the ESCRT-III 
complex for endosomal sorting which results in polyU/
SQSTM1 aggregates.
[162,85]
Amyotrophic lateral sclerosis Impaired early endosomes, impaired sorting/degradation of 
autophagosomes, CHMP2B disturbs the ESCRT-III complex 
for endosomal/MVB sorting which results in polyU/SQSTM1 
aggregates, MVBs are required for TDP-43 clearance, 
Lithium activates protective autophagy.
[232,86,162,233]Molecular Neurodegeneration 2009, 4:16 http://www.molecularneurodegeneration.com/content/4/1/16
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tive larger structures. Efficient bi-directional transport
along the axon is necessary for neuronal survival
[168,169] and supports the clearing of protein aggregates
by autophagosomes [31].
In addition, autophagosomes are retrogradely trans-
ported, making them potential transport vacuoles for the
delivery of trophic factors from the synapse to the cell
body. Autophagosomes can travel along microtubules,
possibly facilitated through an interaction between
MAP1LC3 and MAP1A/B [29,41]. Some evidence exists
that signaling endosomes containing nerve growth factor
(NGF) might be derived from or be related to autophago-
somes, based on the microscopic association of fluores-
cently labeled LC3 with retrogradely transported NGF and
the NGF receptors TrkA and p75 [170]. This finding could
indicate that disturbed autophagy (for example, as a result
of changes in APP expression or metabolism) might con-
tribute to the reported impairment of NGF transport in
neurodegenerative diseases such as Down's syndrome. In
this condition, an extra copy of chromosome 21, which
contains the APP gene, results in increased APP expression
and the development of Alzheimer-like dementia. Intrigu-
ingly, in a trisomic mouse model of Down's syndrome
deletion of one copy of APP led to a marked improvement
in transport of signaling endosomes containing NGF,
reduced neurodegeneration, and improved cognitive
function [171].
Several studies point towards an important role of ULK1
in this trafficking role of autophagy. For example, knock-
down of ULK1 by RNAi in cultured mouse spinal sensory
neurons leads to impaired endocytosis of NGF [107].
Axonal growth appears stunted in C. elegans in unc-51
mutants [110,112] and after ULK1 knockdown in mouse
neuronal cells [107], while dominant negative ULK1
mutants expressed in immature murine cerebellar granule
cells lead to inhibition of neurite outgrowth and develop-
mental arrest [99]. ULK1 is important for autophagy initi-
ation and has been reported to interact with GABARAP
and GABARAPL2 (also known as GATE16), two homo-
logues of MAP1LC3, in mouse pyramidal, mitral, and
Purkinje cells. This interaction indicates an involvement
of autophagosome transport in some of the ULK1 knock-
down phenotypes [92], although it clearly has functions
independent of autophagy [100,172].
Another interaction between autophagy and neuronal
receptors was found in Lurcher mice, which have a muta-
tion in the glutamate receptor GluRδ2 and are a model for
ataxia. The mutated receptor GluRδ2Lc, but not the
wildtype receptor, bind to BECN1 and may thus trigger
autophagy in dying Purkinje cells in Lurcher mice
[173,174]. In this way, autophagy might serve as an early
stress response to axonal dystrophy. Autophagosomes
appear rapidly in axons in Lurcher mice and this is attrib-
uted to the induction and local synthesis of autophago-
somes in axon terminals in response to stress [174]. How
autophagosomes form so fast in distal cell parts is unclear,
but early ultrastructural studies suggest that smooth ER in
axons might be a source for quick membrane supply
[175,176].
Table 4: Autophagy in acute neuronal injury.
Injury Autophagy related changes Ref.
Hypoxia/Ischemia Mixed results after hypoxic treatments: Knockout of Atg 
genes in C. elegans decreases survival after hypoxia and 
autophagy activation by rapamycin treatment leads to injury 
reduction in rat and rat tissue. On the contrary, Atg7-/- mice 
lacking functional autophagy in the CNS are largely 
protected from neurodegeneration.
[247,80,104,94,244,246,245]
Trauma Macroautophagy appears to be beneficial: Autophagy can be 
activated for more than a month following brain trauma 
(elevated BECN1, MAP1LC3-II, ATG5-12 levels, increased 
AV numbers) in rodents, autophagy appears activated in 
human tissue samples. Rapamycin treatment is 
neuroprotective in mice.
[106,87,249,248,65,95,84,81,250]
Pharmacological injury Autophagy appears to be deleterious: Transient activation of 
autophagy after injury (elevated MAP1LC3-II, p-mTOR, 
LAMP2, increased AV numbers) and activation of apoptosis 
in rodents and primary neuronal culture. 3-MA treatment or 
RNAi against ATG5 or BECN1 blocks cell death.
[96,252,166,103,253,251,254]
Trophic deprivation Autophagy appears to be deleterious: Growth factor 
withdrawal leads to autophagic cell death in rodents or 
chicken, 3-MA blocks cytochrome C release and delays 
apoptosis.
[257,255,256,259,258]Molecular Neurodegeneration 2009, 4:16 http://www.molecularneurodegeneration.com/content/4/1/16
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Regulation of autophagy
Because of its key function in cell homeostasis, multiple
signaling cascades have been implicated in the regulation
of autophagy (Fig. 3). A large amount of this knowledge
has been acquired in yeast and it is unknown how much
can be translated to mammalian cells (for reviews see
[177-179]). One of the key regulators of autophagy is the
level of amino acids, both extracellular and intracellular.
Cells measure intracellular amino acid levels via the pro-
tein kinase EIF2AK4 (also known as GCN2), which is acti-
vated by unloaded transfer RNAs. Low levels of
intracellular amino acids leading to free transfer RNAs
thus activate autophagy through phosphorylation of the
eukaryotic initiation factor eIFα2 [180]. Extracellular
amino acids are sensed via a putative receptor in the cell
membrane [181], which seems to signal through mam-
malian target of rapamycin (mTOR, also known as
FRAP1). mTOR is a protein kinase that plays a central role
in nutrient sensing, cell proliferation, and metabolism
[182-184], integrating many signaling pathways. Acti-
vated mTOR promotes protein synthesis and inhibits
autophagy via phosphorylation of the ULK1 binding part-
ner ATG13, while deactivated mTOR activates autophagy
[185]. Insulin and growth factors signal through AKT, acti-
vate mTOR [182,186] and deactivate autophagy, while
energy depletion [187] or elevated intracellular calcium
[188] inhibit mTOR through AMP-activated protein
kinase (AMPK) and activate autophagy. Other signaling
cascades implicated in the regulation of autophagy
include Ras/Raf and ERK signaling (mTOR dependent
[189] or independent [190]) and the mTOR independent
inositol signaling pathway [191,192]. Lastly, autophagy
may be induced "directly" through the presence of intrac-
ellular inclusions [193-195]. It is unclear which of these
pathways are involved in neurodegenerative conditions.
Even less is known about the transcriptional control of
autophagy, especially in neurons. Nevertheless, a number
of important transcription factors have been associated
with the regulation of autophagy genes in non-neural cell
types. Since these processes are likely conserved, they may
contribute to the control of autophagy in neurons as well.
In one study, a high-affinity E2F4 transcription factor-
binding region in the BECN1  promoter was identified
[196]. A number of autophagy proteins are also control-
led by the FOXO3 transcription factor in muscle cells
[197,198] and potentially hepatoma and pheochromocy-
toma cells [198]. In these cell types, FOXO3 binds directly
to the promoters of MAP1LC3,  ATG12, and GABARAP
genes to increase their expression and induce autophagy
[197]. Indeed, FOXO3 increases the expression of ATG4,
PIK3C3 and BECN1, but the exact mechanisms are
unknown [198].
Members of the p53 family also play important roles in
autophagy control: Cytosolic p53 inhibits autophagy
[199], whereas nuclear p53 activates it [200]. The localiza-
tion of p53 appears to be a sensor for genotoxic stress. In
addition, p53 acts upstream of mTOR, inhibiting its activ-
ity through AMPK, thus stimulating autophagy. Recently,
a p53 homologue, p73, has been identified by integrating
whole-genome chromatin immunoprecipitation and
expression profiling in cell culture that binds to regulatory
regions of several autophagy genes (ATG5, ATG7, UVRAG,
GABARAP, AMBRA1, ATG16, PIK3C3) presumably
through its nuclear activity [201,202]. Further studies that
investigate the upstream control of autophagy in neurons
will greatly help to improve our understanding of the
potential misregulation of autophagy during neurodegen-
eration.
The above findings suggest three main roles for autophagy
in neuronal homeostasis: First, impaired autophagy
results in abnormal protein aggregation across species,
indicating an involvement of autophagy in the clearance
of intracellular protein aggregates, especially when these
aggregates are poly-ubiquitinated. Second, changes in
vesicular appearance and trafficking point towards a cru-
cial role of autophagy in maintaining the normal turnover
and flux of vacuolar compartments and possibly trophic
factors through the neuron. And third, disrupted
autophagy leads to changes in neuronal morphology and
connectivity, such as excessive axon arborization, stunted
axon growth, axonal dystrophy, axonal terminal degener-
ation or impaired axonal projections, implicating
autophagy genes and their gene products in neuronal
shaping, connectivity, and development. Whether these
observations are always directly linked to the gene's role
in autophagy or are sometimes a result of non-autophagic
functions remains to be determined.
Autophagy in CNS disease and injury
Several excellent reviews have recently covered the emerg-
ing relationship between autophagy and various neurode-
generative diseases [10-13] and we provide only a brief
overview of the most prevalent diseases associated with
histopathological changes in autophagy. Instead, we sum-
marize here which aspects of autophagosomal pathology
that have been observed in human disease are now being
successfully replicated in model systems (Tab. 3 and 4).
In general, the effect of autophagy in neurons during dis-
ease can be broadly divided into two classes: autophago-
somal degradation is either impaired or excessively
activated, leading to an apparent disruption of the intrac-
ellular organelle organization and accumulation of
autophagosomes in neurons over long periods of time
(chronic conditions, Tab. 3), or autophagy genes are acti-Molecular Neurodegeneration 2009, 4:16 http://www.molecularneurodegeneration.com/content/4/1/16
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vated in response to temporary injury/stress (acute
response, Tab. 4).
Autophagy in chronic CNS diseases
Typical examples of the first class of diseases are Alzhe-
imer (AD) [57-59,62,118,203-209], Parkinson (PD)
[102,117,192,210-220], and Huntington disease (HD)
[195,203,216,221-231] (Tab. 3). In these diseases, the
pathological accumulation of autophagosomes/
autophagosome-like structures and abnormalities in the
endosomal-lysosomal pathway were documented by elec-
tron microscopy (EM) in human postmortem brain tissue
[57,58,117,118,207]. Diseases with a seemingly more
endosomal pathology, but an autophagic component, are
Amyotrophic lateral sclerosis (ALS) and Frontotemporal
dementia (FTD) [85,86,162,232,233].
In Alzheimer research, expression analysis revealed that
BECN1 mRNA is reduced in AD brain tissue [59,234], and
BECN1 protein levels are significantly lower in the cortex
of AD patients compared with age-matched controls [59].
This is despite the fact that an increase in autophagosome
numbers in neurons from AD patients is obvious by EM,
and AD brains also show increased levels of MAP1LC3-I
and MAP1LC3-II [58]. A possible explanation for this
apparent contradiction is that reduced BECN1 levels lead
to changes in autophagosomal flux. This in turn could
impair endosomal-lysosomal degradation, leading to a
built-up of intracellular vesicular compartments over
time. Changes in the endosomal-lysosomal pathway are
amongst the earliest changes in AD [235] and a possible
indicator for disturbed vacuolar trafficking.
While the aforementioned studies were descriptive, one of
the first mechanistic insights into the possible role of
autophagy in neurodegenerative diseases was provided by
a study of primary neurons from a mouse model for HD.
The authors observed increased autophagy, increased oxi-
dative stress, and polyU aggregates in cultured striatal
neurons from transgenic mice expressing mutant human
huntingtin in response to a single exposure of a neuro-
toxic concentration of dopamine [223]. The results sug-
gest that dopamine triggered free radical-mediated
oxidation of macromolecules and stimulated autophagy.
Subsequent studies demonstrated that SQSTM1 exten-
sively decorates polyU protein aggregates, co-localizes
with MAP1LC3 and becomes sequestered in autophago-
somes. This highlights the importance of autophagy as a
degradative pathway for polyU aggregates [43]. Another
link between autophagy and protein aggregates was pro-
vided by a study showing that mTOR accumulates in
huntingtin aggregates in cells, mice, and human brains
[226]. The authors speculate that mTOR can be seques-
tered and inactivated in this way, leading to a protective
induction of autophagic degradation of protein aggre-
gates. Arguing against this interpretation is the observa-
tion that BECN1, a protein necessary for the induction of
autophagy, is recruited into pathological huntingtin
aggregates in human brain tissue as well [230].
The effect of autophagy on the degradation of protein
aggregates was investigated further in cell culture and ani-
mal models using pharmacological inducers and inhibi-
tors of autophagy (see Tab. 4). It was discovered that
rapamycin, an inducer of autophagy, leads to the clear-
ance of polyQ/polyA aggregates in cell culture, fly, and
mouse models of HD [195,226]. This finding was con-
firmed for α-synuclein in cell culture [218] and wildtype
tau in flies [203]. Together, these results triggered a con-
Control of autophagy Figure 3
Control of autophagy. Autophagy is a major housekeeping 
pathway and under the control of many different signaling 
cascades. Mammalian Target of rapamycin (mTOR) plays a 
central role in the regulation of autophagic activity as it inte-
grates signaling from different sensors of cellular homeosta-
sis. When mTOR is active in yeast it keeps an important 
ULK1 binding partner (ATG13) phosphorylated, thus inhibit-
ing the induction of autophagy. While signals indicating abun-
dant nutritional and trophic support activate mTOR (and 
deactivate autophagy), signals of starvation or other stres-
sors inhibit mTOR (and activate autophagy). Autophagy can 
be directly stimulated by intracellular debris (such as 
unfolded proteins and damaged organelles) or by indicators 
of an overwhelmed ubiquitin-proteasome system (UPS). Also 
certain pathogens activate autophagy. Autophagy can be 
directly inhibited by genetic ablation of important Atg genes, 
inhibitors of the class III PI3K-complex (WM, 3-MA), high 
nutrient levels, and inositol signaling. More recently screen-
ings of small compound libraries have yielded inducers and 
inhibitors of autophagy, both mTOR dependent and inde-
pendent. And last, transcriptional regulators, such as p53, 
eIF2α, E2F4, or FOXO3 regulate autophagy by controlling 
the expression levels of many Atg genes. For further details, 
please refer to the text.
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certed research effort to find mTOR dependent and inde-
pendent pharmacological inducers of autophagy and led
to the discovery of many small compounds that facilitate
the clearing of aggregated proteins [216,219,229,236].
While pharmacological autophagy stimulation reduces
the toxicity of many aggregate-prone proteins, experi-
ments in cell culture demonstrate that α-synuclein can be
degraded by both the proteasome and autophagy. Phar-
macological inhibition of either pathway leads to
increased intracellular α-synuclein levels [218]. Interest-
ingly, pharmacological inhibition of microtubule forma-
tion by nocodazole treatment inhibits polyQ aggregate
formation and at the same time increases its toxicity in cell
culture [237,238]. This is at least partially due to the inhi-
bition of autophagosome-lysosome fusion [239], demon-
strating that intracellular transport is essential for proper
aggresome/inclusion body formation and autophago-
somal function. Furthermore, activation of autophagy
through starvation in primary cortical mouse neurons
expressing polyQ proteins protects against cell death
[186]. In summary, autophagy might be especially effec-
tive in clearing aggregated proteins.
While these pharmacological studies increase our under-
standing of some aspects of autophagy in neurodegenera-
tion, they mostly employ drugs that are rather nonspecific
and they target proteins such as mTOR and AKT, which
have broad functions outside autophagy. Genetic or
RNAi-based methods overcome some of these limitations.
It has been shown, for example, that cytosolic protein
aggregates can be specifically targeted by autophagy and
that their aggregation increases after inhibition of
autophagy by siRNA knockdown of MAP1LC3 in cell cul-
ture [221]. In C. elegans, RNAi mediated deletion of bec-1,
atgr-7, and Ce-atg18  led to increased accumulation of
polyQ aggregates in models for HD, confirming the earlier
studies in mammalian cell culture systems [124].
The cytoplasmic histone deacetylase HDAC6, although
not directly an autophagy related protein, plays an essen-
tial role in the microtubule- and dynein-dependent intra-
cellular movement of polyU protein aggregates [240].
HDAC6 RNAi impairs retrograde transport of autophago-
somes and lysosomes [156]. HDAC6 overexpression, on
the other hand, is sufficient to rescue neurodegeneration
caused by proteasome mutations or polyQ toxicity in
transgenic flies via autophagy, providing a direct link
between UPS and autophagy [157]. HDAC6 activates
autophagy by an unknown mechanism, leading to accel-
erated protein turnover. Potential mechanisms include
modulation of HSP90 (and maybe CMA), a substrate of
HDAC6 [241], accelerated transport of polyU-proteins
into aggregates and to autophagosomes [240], and
enhanced transport of lysosomes to autophagosomes
[156]. The importance of autophagosomal transport for
effective clearance of aggregated proteins has been dem-
onstrated in HD fly and mouse models, where dynein
mutations caused increased aggregate formation and
decreased autophagosome-lysosome fusion [31].
Recently, autophagy was genetically manipulated in a
mouse model of AD by crossing Becn1  heterozygous
knockout mice (Becn1+/-) with human amyloid precursor
protein (APP) transgenic mice. Becn1 deficiency resulted
in neurodegeneration and increased β-amyloid (Aβ) dep-
osition in APP mice [59]. Based on these findings and new
cell culture data from our lab (Jaeger et al., manuscript in
preparation) we propose that autophagosomes can
degrade APP and thus lower Aβ accumulation [59]. On
the other hand, autophagosomes contain the enzymes
necessary for processing of APP into Aβ and are potential
producers of this toxic peptide [58]. A decisive factor that
determines whether autophagy reduces or promotes Aβ
accumulation might be the speed of autophagosomal
turnover and the clearance of autophagic vesicles. Both
are impaired under disease conditions [62]. Disturbances
in autophagy initiation due to insufficient BECN1 levels
could cause expansion of the endosomal-lysosomal sys-
tem, producing a high load of potentially Aβ generating
vacuoles. Interestingly, two APP mouse models for AD
have been analyzed for changes in Becn1 levels, but no
differences were detected [59]. These findings hint at an
autophagy dysfunction upstream of APP pathology in AD.
CMA is also clearly involved in chronic neurodegenerative
diseases, most prominently in PD: HSP90 levels are
increased in human PD brains and are correlated with the
levels of insoluble α-Synuclein [242]. In the same study,
immunohistochemistry and EM show that HSP90 co-
localizes with α-synuclein in Lewy bodies, Lewy neurites,
and glia cell inclusions, both in PD patients and α-synu-
clein transgenic mice. Furthermore, HSP90 and HSC70
co-immunoprecipitate with α-synuclein in cell culture
[242]. While this could indicate increased (protective)
CMA in PD, a recent gene expression profiling of substan-
tia nigra tissue from sporadic PD patients revealed
reduced expression of UPS proteins and reduced HSC70
[243]. At some point during disease progression, HSP90
may be sequestered into α-synuclein aggregates and deac-
tivated, thus reducing CMA activity.
A landmark study identified α-synuclein as a target for
CMA and demonstrated that the PD associated mutations
A53T and A30P cause α-synuclein to bind to the CMA
receptor and inhibit both the degradation of the receptor
itself and that of other CMA substrates [210]. While these
α-synuclein mutations are relatively rare, recent findings
demonstrate that post-translational modifications of
wildtype α-synuclein through dopamine can cause a sim-
ilar toxic gain-of-function behavior [213]. Furthermore,
inhibition of CMA by lentiviral RNAi against LAMP2Molecular Neurodegeneration 2009, 4:16 http://www.molecularneurodegeneration.com/content/4/1/16
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increases the level of endogenous α-synuclein in rat corti-
cal neurons [102]. Additionally, a link has been suggested
between the PD associated mutant ubiquitin carboxyl-ter-
minal esterase L1 (UCH-L1) and the lysosomal receptor
for chaperone-mediated autophagy. This mutant UCH-L1
interacts aberrantly with LAMP2, HSC70, and HSP90,
inhibits CMA and causes an increase in α-synuclein in cell
culture [212].
While the role of autophagy in neurodegenerative diseases
is far from being understood, the available data indicate it
plays an integral role in the cellular response to intracellu-
lar protein aggregation common to these diseases.
Autophagy appears impaired in the final stages of neuro-
degenerative diseases, whereas alterations in vacuolar traf-
ficking are apparent in early stages, often before other
histopathological changes manifest themselves. It is there-
fore likely that autophagy, UPS, the endosomal-lysosomal
pathway, and the escalating accumulation of toxic pro-
teins are tightly connected. Whether mutant or misfolded
proteins are causing the changes in vacuolar trafficking
and later autophagy or whether abnormalities in these
protein degradation pathways precede protein aggrega-
tion remains to be shown.
Autophagy in acute CNS diseases and injuries
The second class of brain insults that present with an
autophagy phenotype are acute injuries or stressors which
activate competing cellular death and pro-survival path-
ways (Tab. 4). Examples include hypoxia/ischemia
[80,94,104,244-247], brain trauma [65, 81,84, 87,95,
106,248-250], experimental pharmacological injury
models (kainate, methamphetamine, oxidative stress and
others) [96,103,166,251-254], and trophic factor depriva-
tion [255-259]. Similar to chronic neurodegenerative con-
ditions, many observational studies find increased levels
of autophagy proteins and/or numbers of autophago-
somes after acute CNS injury such as hypoxia/ischemia or
trauma [81,87,94,95,104,106,244,246,248,250].
As described in the previous chapter above, autophagy has
beneficial functions in neurons that seem to be relevant
for acute injury as well. For example, the autophagy
inducing drug rapamycin reduced brain injury and pro-
tected neurons in a rat model of neonatal hypoxia/
ischemia [80,249] or traumatic brain injury in mice
[80,249]. Consistent with these findings, RNAi mediated
knockdown of bec-1, lgg-1, and lgg-2, or mutation of unc-
51 reduced survival after hypoxia in C. elegans [247].
However, in contrast to most studies in chronic degenera-
tive models, acute pharmacologically induced injury or
withdrawal of trophic support triggered cell death that
involved autophagy and signs of apoptosis (Tab. 4). In
support for a role in promoting cell death, inhibition of
autophagy by 3-methyladenine (3-MA) treatment,
decreased the toxic effects or delayed neuronal loss after
noxious treatments [103,253,254,260]. Likewise, knock-
down of ATG5 or BECN1 by RNAi reduced cell death in
photoreceptor cells that were exposed to oxidative stress
[253]. Maybe most convincingly, Atg7flox/flox;nestin-Cre
mice lacking Atg7 in the neuronal lineage are almost com-
pletely protected against stroke-induced neurodegenera-
tion [245].
Why seemingly similar studies come to these opposing
conclusions is not clear at this point but differences in the
models, the tools used to analyze autophagy, or the time
of analysis after injury could be responsible. In support of
the last point, autophagy was still increased in surviving
cells at the injury site one month after traumatic brain
injury [106] while cells undergoing necrotic or apoptotic
death (and possibly involving autophagy in its detrimen-
tal role) would likely have disappeared. It will therefore be
interesting to explore whether inhibiting autophagy early
or late after a traumatic brain injury may have different
outcomes. In addition, a better understanding of how
exactly autophagy contributes to cell death and how it
interacts with necrotic and apoptotic death programs is
necessary.
Autophagy and Apoptosis
As described in the previous chapters, autophagy in the
CNS can be protective under some circumstances, while it
leads to cell death in others. Furthermore the resulting cell
death can be either apoptotic (type I cell death) or
autophagic (type II cell death), depending on the cellular
setting and inducing stressor (see also reviews [133,158]).
This dichotomous role of autophagy is the result of a com-
plex relationship between the autophagy and apoptosis
pathways (Fig. 4). While some mixed phenotypes have
been reported [261-263], autophagy and apoptosis ulti-
mately develop in a mutually exclusive way and appear to
inhibit each other [264-267].
Strong evidence for a role of autophagy as an alternative
cell death mechanism comes from mice deficient in apop-
tosis. One of the key features of apoptotic cell death is the
mitochondrial outer membrane permeabilization
(MOMP), which requires the two BCL2 family proteins
BAX and BAK1. Cells from Bax-/-Bak-/- knockout mice are
resistant to various apoptotic stimuli, but can die through
a delayed autophagic cell death in response to DNA dam-
age [268]. Autophagic cell death can also be observed after
caspase inhibition, a treatment that disrupts normal
apoptosis [266]. Conversely, inhibition of autophagy via
RNAi targeting various autophagy genes (ATG5,  ATG7,
BECN1) can reduce autophagic cell death in certain situa-
tions [268-270].Molecular Neurodegeneration 2009, 4:16 http://www.molecularneurodegeneration.com/content/4/1/16
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In contrast to its function as a cell death mechanism,
autophagy is induced under starvation conditions to sup-
ply the cell's metabolic needs. Under these conditions,
inhibition of autophagy results in cell death [8]. Even
without starvation, loss of autophagy itself (as in the Atg5-
/- or Atg7-/- knockout mice) is sufficient to cause neuronal
apoptosis [60,61], and it has been suggested that
autophagy is primarily a pro-survival pathway [271].
It has been shown that autophagy and apoptosis share
common inducers such as reactive oxidative species
(ROS), ceramide, and intracellular calcium [188,272-
275]. The two pathways are further linked through ATG5
proteolysis [275], the transcription factor p53 [276], and
the BCL2 protein family (via BECN1) [277] (Fig. 4). How
the balance between autophagy and apoptosis is main-
tained in neurons requires further investigation.
Concluding remarks
Unknown to most neuroscientists just a few years ago,
autophagy has gained increasing attention not only from
translational researchers but also from basic neuroscien-
tists interested in neuronal cell biology. Consequently,
there are few answers as to the role and relevance of
autophagy in neurons, let alone in glia cells, and very few
genetic in vivo studies have been conducted to investigate
its role in neurological disease. Nevertheless, it seems
clear that neurons require autophagy for normal function
and that neuronal stress will rapidly trigger this pathway
(see Appendix 1: Key Observations). There is growing con-
sent that intraneuronal protein aggregates trigger
autophagy and that this response is beneficial – at least in
its intent. This notion is supported by a limited number of
pharmacological and genetic studies in animal models,
which demonstrate that reduced autophagy promotes
neurodegenerative disease while increased autophagy is
beneficial. In contrast, work from stroke models and other
acute forms of neural injury indicate that autophagy can
be detrimental in such circumstances and promotes cell
death. It will be necessary to employ state of the art genetic
and molecular tools to dissect the role of autophagy in
normal and pathological conditions in cell culture and in
mammalian disease models (see Appendix 2: Critical
Next Steps). Conditional knockout mice are being devel-
oped or are already available to target autophagy not only
in neurons but also in astrocytes, oligodendrocytes and
microglia. Such studies are likely to add additional com-
plexity to our understanding of autophagy but they may
also uncover new therapeutic opportunities. Self-eating,
after all, does not equate with self-destruction but may in
fact be a powerful survival pathway for the cell, and as
such, of key importance to neurodegeneration or neuro-
protection.
Abbreviations
3-MA: 3-Methyladenine; Atg: Autophagy related genes;
AD/PD/HD: Alzheimer/Parkinson/Huntington disease;
APP: Amyloid precursor protein; AV: Autophagic vesicles;
CMA: Chaperone-mediated autophagy; CNS: Central
nervous system; EM: Electron microscopy; ER: Endoplas-
matic reticulum; htt: Huntingtin; MOMP: Mitochondrial
outer membrane permeabilization: MVB: Multivesicular
body; NGF: Nerve growth factor; PE: Phosphoeth-
anolamine; PI3K: Phosphoinositide 3-kinase; polyQ/
polyA/polyU: Proteins with long sequences of Glu/Ala or
that are ubiquitin decorated; Rap: Rapamycin: ROS: Reac-
tive oxidative species: UPS: Ubiquitin-proteasome system;
WM: Wortmannin;
Competing interests
The authors declare that they have no competing interests.
Appendix 1
Key Observations
￿ Autophagy plays a crucial role in maintaining neuro-
nal homeostasis through clearance of defective
organelles and unfolded/aggregating proteins. Knock-
out of autophagy pathway genes leads to accumula-
tion of poly-ubiquitinated protein aggregates and can
result in neurodegeneration, and motor and behavio-
ral deficits in mice.
￿ Autophagy interacts with other protein degradation
and vesicular trafficking pathways. While autophagy
can at least partially substitute for reduced proteaso-
mal activity and vice versa, the disturbance of the
endosomal-lysosomal system disrupts autophagy and
reduced autophagy impairs endosomal-lysosomal
trafficking.
￿ Autophagy clears neurotoxic proteins. Activation of
autophagy reduces the toxicity of aggregation prone
proteins, while inhibition of autophagy impairs their
clearance and causes enhanced cellular stress and neu-
rodegeneration.
￿ Autophagy can be a cellular death pathway, which is
activated in neurons after acute injury and inhibition
of autophagy under those conditions can reduce neu-
rodegeneration.
￿ Autophagy is impaired in the final stages of most
neurodegenerative diseases.
Appendix 2
Critical Next Steps
￿ What is the sequence of events? Impaired autophagy
is a histopathological hallmark of many neurodegen-Molecular Neurodegeneration 2009, 4:16 http://www.molecularneurodegeneration.com/content/4/1/16
Page 15 of 22
(page number not for citation purposes)
erative diseases. But it is unknown if autophagy is first
impaired, contributing to the disease early on, or if
autophagy is highly active to fight the disease and is
overwhelmed in the end. The use of inducible knock-
out animals crossed with traditional disease models or
RNAi against autophagy genes in different disease
stages could help to elucidate this problem.
￿ Which autophagy genes are involved? Autophagy is
mediated through an evolutionary conserved pathway
involving more than 20 proteins. Several of them link
autophagy to other important cellular pathways such
as apoptosis, the ubiquitin/proteasome system, the
endosomal-lysosomal system, and vesicle and recep-
tor trafficking. Which proteins are involved in neuro-
degeneration is not well understood. Careful analysis
of autophagy activity, and mRNA and protein levels of
central autophagy genes in tissue from human
patients and animal models could help us identify the
key players.
￿ What genetic mutations are associated with autophagy
and altered susceptibility to neurodegeneration? While
some data exist about mutations in disease-associated
genes that interact with autophagy, no mutations in
human autophagy genes that cause neurodegeneration
are known so far. If autophagy plays a central role in pro-
tein clearance, the identification of change-of-function
mutations in autophagy genes would be essential to
define "autophagosomal diseases".
￿ How can autophagy be modulated to enhance clini-
cal outcome? The discovery of drugs beyond rapamy-
cin to enhance autophagy has made substantial
progress. Because autophagy is linked with multiple
intracellular pathways, the identification and func-
tional characterization of key proteins that specifically
control only limited aspects of this interplay could
help design more precise modulators of autophagic
activity, with lessened effects on connected pathways.
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